Table 1

Demographic Data of the Study and Control Groups
Study group (group A) Control group (group B) p-value
Age (years ± SD) 41.28 ± 5.07 39.48 ± 6.95 0.27
Sex (M/F) 23/6 25/4 0.49
Duration before diagnosis (days ± SD) 13.24 ± 9.65 17.55 ± 9.66 0.09
Initial VA (logMAR ± SD) 0.23 ± 0.27 0.27 ± 0.20 0.59
Initial CMT (microns ± SD) 524.28 ± 175.95 508.69 ± 135.31 0.70
FA findings at baseline
- inkblot leakage 26 26 -
- smokestack leakage 3 3 1.00

Study group (group A): the group received antioxidant tablets.

Control group (group B): the group received placebo tablets.

SD = standard deviation.

M = male, F = female, VA = visual acuity.

logMAR = logarithm of minimum angle of resolution.

CMT = central macular thickness.

FA = fluorescein angiography.

Ratanasukon et al.

Ratanasukon et al. BMC Ophthalmology 2012 12:20   doi:10.1186/1471-2415-12-20

Open Data